Sensient shareholders reelect all director nominees, approve say-on-pay, 1-year frequency, ratify EY

Ratification of Independent Auditors The Company’s shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent auditors for the year ending December 31, 2023 by the following votes: Votes For Votes Against Abstentions 38,792,493 355,501 45,088

Election of Directors The following directors were each elected until the next annual meeting of shareholders and until his or her successor is elected and, if necessary, qualified: Nominee Votes For Votes Against Abstentions Broker Non-Votes Dr. Joseph Carleone 37,367,688 524,750 32,826 1,267,817 Kathleen Da Cunha 37,815,654 80,108 29,502 1,267,817 Dr. Mario Ferruzzi 37,529,900 362,667 32,697 1,267,817 Carol R. Jackson 37,540,240 350,352 34,672 1,267,817 Sharad P. Jain 37,577,400 314,684 33,180 1,267,817 Dr. Donald W. Landry 37,425,223 464,868 35,173 1,267,817 Paul Manning 34,945,676 2,923,087 56,501 1,267,817 Deborah McKeithan-Gebhardt 37,567,962 324,642 32,660 1,267,817 Scott C. Morrison 37,433,491 461,936 29,837 1,267,817 Essie Whitelaw 37,426,752 438,999 59,513 1,267,817

Advisory Vote on the Frequency of Voting to Approve Named Executive Officer Compensation The Company’s shareholders approved, on an advisory basis, holding an advisory vote on the compensation of the Company’s named executive officers every one (1) year. The votes were as follows: 1 Year 2 Years 3 Years Abstentions Broker Non-Votes 36,375,497 311,067 1,198,747 39,954 1,267,817

Advisory Vote to Approve Named Executive Officer Compensation The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s 2023 proxy statement, by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 34,529,383 3,325,776 70,105 1,267,817